| 1 |
29298867 | Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. | 2018 Jan 3 |
2 |
| 2 |
29772028 | Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1. | 2018 |
1 |
| 3 |
26842068 | Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo. | 2016 Feb |
1 |
| 4 |
26176329 | Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. | 2015 Sep 17 |
3 |
| 5 |
25084341 | Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC). | 2014 Aug |
2 |
| 6 |
20064157 | Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis. | 2010 Mar |
1 |
| 7 |
20298204 | Drug targets for amyloidosis. | 2010 Apr |
1 |
| 8 |
19372378 | Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. | 2009 May 5 |
2 |
| 9 |
12015594 | Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. | 2002 May 16 |
1 |